Genetically Modified Cells TRIZ Cases
- Myeloid Progenitor Cell Expansion via MYC and BMI1 Overexpression
Overexpressing MYC and BMI1 genes in hematopoietic progenitors enables stable myeloid expansion while avoiding cancer risks associated with immortalized lines.
- Engineered Cell Lines for Cultivated Meat Production
Knocking out LDHA and PDK1 genes reduces lactate accumulation in fed-batch processes, maintaining high viable cell density.
- Induced Hepatic Stem Cells for Human Liver Function Evaluation
Induced hepatic stem cells replicate human liver metabolic functions using defined gene combinations.
- Sox17-Expressing Reprogrammed Endothelial Cells for Stable Vascular Integration
Sox17-expressing reprogrammed endothelial cells overcome instability and immature cell issues to enable durable vascular regeneration.
- Bispecific Autoantibodies Targeting Secreted Tumor Antigens
Bispecific autoantibodies overcome antigen heterogeneity by targeting secreted proteins, recruiting T cells to enhance cytolytic activity.
- Targeted Integrated Cell Nucleic Acid Fragment Integration
Defined nucleic acid fragment with recombinase-mediated recombination eliminates random integration screening.
- Co-culture System for Generating Homogeneous Cancer Stem Cells
Co-culturing immortalized cells with mesenchymal stem cells produces homogeneous cancer stem cell lines with reduced chromosomal aberrations.
- Chimeric Animal Germ Line Transmission via Fertility Gene Disruption
Disrupting host fertility genes eliminates endogenous gamete competition, ensuring reliable donor cell integration into chimeric offspring.
- Cell Culture Medium Lithium Ethanol Fatty Acids
A cell culture medium containing lithium ions, ethanol, and fatty acids increases recombinant polypeptide titers.
- T Cell Expansion Using Cytokines and NAC
Adding cytokines and N-acetylcysteine to culture media expands T cell populations while maintaining genetic alterations.
- Human BDCA-2 Antibody Variable Region Engineering
Optimized human BDCA-2 antibody variable regions bind pDCs to inhibit IFNα production.
- Direct Transdifferentiation of Fibroblasts to Immune Effector Cells
Direct transdifferentiation of fibroblasts via Tbet, Tcf7, and Ets1 bypasses pluripotent stem cell complexity for scalable CAR-T production.
- Non-integrating Vector iPSC Induction from Neural Stem Cells
Culturing neural stem cells with non-integrating vectors expressing reprogramming factors to generate pluripotent stem cell clones.
- Mesenchymal Stem Cell Differentiation via NICD Transfection
Transfecting marrow stromal cells with Notch intracellular domain nucleic acids alters developmental potential.
- FoxP3 T Regulatory Cells Enhance Ovarian Repair
FoxP3-expressing T regulatory cells inhibit apoptosis and inflammation in ovarian tissues, restoring function despite unclear cellular mechanisms.
- Gene Therapy Vector Safety Testing via iPSC Integration Analysis
Induced pluripotent stem cell cultures enable in vitro gene therapy vector infection and nucleic acid extraction for expression analysis.
- Engineered Stem Cells Modulate Bioelectric Properties for Cardiac Repair
Engineered stem cells overexpress KCNN4 genes to hyperpolarize transmembrane potential and enhance cellular reparative functions.
- CAR Treg Cells for Immune Rejection Prevention
Engineered CAR regulatory T cells recognize transplant antigens to induce localized immune tolerance.
- Meta-tyrosine Supplementation for Eukaryotic Cell Productivity
Adding meta-tyrosine to the medium raises specific productivity by 5-25% while avoiding apoptosis from traditional valproic acid shifts.
- Human Artificial Chromosome Vector Production in Xeno-Free Cells
Eliminating endogenous genes from human chromosomes creates safe vectors for clinical use, avoiding contamination from mouse or chicken cell lines.
- Non-integrating Vector System for iPS Cell Reprogramming
A non-integrating vector system delivers reprogramming factors to generate induced pluripotent stem cells without viral integration.
- Retroviral Vector Delivery of Reprogramming Factors
Retroviral vectors deliver Oct3/4, Sox2, Klf4, and c-Myc to reprogram somatic cells into induced pluripotent stem cells without embryos.